hydrazine has been researched along with Soft Tissue Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fuchs, J; Honisch, S; Lang, F; Schleicher, S; Schmid, E; Seitz, G; Stagno, MJ; Yan, J; Yu, W | 1 |
| Chawla, SP; Hendifar, A; Kamel, YM; Messam, CA; Patwardhan, R; Staddon, A | 1 |
| Abdul Razak, AR; Baker, S; Carlson, R; Condy, M; D'Angelo, SP; Dickson, MA; Ellis, J; Erinjeri, JP; Friedlander, S; Gounder, MM; Gupta, AA; Jasmine, FH; Kauffman, M; Keohan, ML; Loong, HH; Nyquist-Schultz, K; Rashal, T; Saint-Martin, JR; Salah, S; Schwartz, GK; Shacham, S; Tanner, L; Tap, WD; Unger, TJ; Zer, A | 1 |
2 trial(s) available for hydrazine and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Results of a phase I dose escalation study of eltrombopag in patients with advanced soft tissue sarcoma receiving doxorubicin and ifosfamide.
Topics: Adult; Aged; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Benzoates; Dose-Response Relationship, Drug; Doxorubicin; Female; Humans; Hydrazines; Ifosfamide; Male; Middle Aged; Pyrazoles; Receptors, Thrombopoietin; Sarcoma; Soft Tissue Neoplasms; Thrombocytopenia; Young Adult | 2013 |
Phase IB Study of Selinexor, a First-in-Class Inhibitor of Nuclear Export, in Patients With Advanced Refractory Bone or Soft Tissue Sarcoma.
Topics: Active Transport, Cell Nucleus; Administration, Oral; Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Biopsy; Canada; Capsules; Disease Progression; Drug Administration Schedule; Drug Compounding; Fasting; Female; Food-Drug Interactions; Humans; Hydrazines; Male; Middle Aged; New York City; Pharmaceutical Solutions; Postprandial Period; Sarcoma; Soft Tissue Neoplasms; Tablets; Time Factors; Tomography, X-Ray Computed; Treatment Outcome; Triazoles; Young Adult | 2016 |
1 other study(ies) available for hydrazine and Soft Tissue Neoplasms
| Article | Year |
|---|---|
Serum and Glucocorticoid Inducible Kinase 1-Sensitive Survival, Proliferation and Migration of Rhabdomyosarcoma Cells.
Topics: Antibiotics, Antineoplastic; Benzamides; Cell Culture Techniques; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cell Survival; Doxorubicin; Humans; Hydrazines; Immediate-Early Proteins; Muscle, Skeletal; Oligonucleotide Array Sequence Analysis; Protein Serine-Threonine Kinases; Real-Time Polymerase Chain Reaction; Rhabdomyosarcoma; Soft Tissue Neoplasms | 2017 |